Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-130971
Filing Date
2024-12-23
Accepted
2024-12-23 06:00:18
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2431704-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2431704-2_3seq1.xml 3 4573
  Complete submission text file 0001104659-24-130971.txt   7369
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084231688
MERCK SHARP & DOHME LLC (Reporting) CIK: 0000064978 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38943 | Film No.: 241569605
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38943 | Film No.: 241569606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6600 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6600 DUMBARTON CIRCLE FREMONT CA 94555 650-752-1300
Personalis, Inc. (Issuer) CIK: 0001527753 (see all company filings)

EIN.: 275411038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)